Fertility drugs and cancer: a guideline
Author:
- Practice Committee of the American Society for Reproductive MedicinePMPractice Committee of the American Society for Reproductive Medicine
- 1 December 2016
- journal article
- practice guideline
- Published by Elsevier in Fertility and Sterility
- Vol. 106 (7) , 1617-1626
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer—a systematic review and meta-analysisHuman Reproduction Update, 2012
- High-grade serous ovarian cancer arises from fallopian tube in a mouse modelProceedings of the National Academy of Sciences, 2012
- Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohortHuman Reproduction, 2011
- Use of fertility drugs and risk of endometrial cancer in an Italian case–control studyEuropean Journal Of Cancer Prevention, 2010
- Fertility drugs and the risk of breast cancer: a meta-analysis and reviewBreast Cancer Research and Treatment, 2010
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryAmerican Journal of Surgical Pathology, 2010
- Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohortBritish Journal of Cancer, 2009
- Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer riskInternational Journal of Cancer, 2009
- Cancer Risk After Exposure to Treatments for Ovulation InductionAmerican Journal of Epidemiology, 2008
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006